Home › Heart Failure › Alabama
Heart Failure clinical trials in Alabama
23 studies for Heart Failure are looking for participants at sites in Alabama.
Cities in Alabama
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Diagnostic and Medical Clinic, Mobile
- Mobile Heart Specialists, PC, Mobile
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06424288A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Univ of Alabama Birmingham, Birmingham
RecruitingPhase 2
Ages 40 to 84 · All sexes · Updated Sep 30, 2026 · NCT06979362A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Fairhope
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Advanced Cardiovascular, LLC, Alexander City
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- Cardiology Associates of Mobile, Mobile
Recruiting
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07232030Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- University of Alabama Saint Vincent's Birmingham, Birmingham
- SEC Clinical Research, Dothan
- Eastern Shore Research Institute, Fairhope
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Birmingham
- Research Site, Centreville
- Research Site, Fairhope
- and 4 more
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Alexander City
- Research Site, Fairhope
- Research Site, Huntsville
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 11, 2026 · NCT06307652A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10004 Fairhope, AL Investigational Site, Fairhope
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Birmingham, AL Investigative Site 10012, Birmingham
- Fairhope, AL Investigative Site 10004, Fairhope
- Huntsville, AL Investigative Site 10026, Huntsville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Alabama at Birmingham Hospital, Birmingham
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Heart Center Research, LLC, Huntsville
- Mobile Infirmary Medical Center, Mobile
Recruiting
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07069738A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 156, Birmingham
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Eastern Shore Research Institute, LLC, Fairhope
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 27, 2026 · NCT06793371Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Birmingham
RecruitingObservational study
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Alexander City
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Aug 19, 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Advanced Cardiovascular, LLC, Alexander City
- Univ of Alabama Birmingham, Birmingham
- Eastern Shore Rsrch Inst, LLC, Fairhope
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Recruiting
Ages 60 and older · All sexes · Updated Aug 14, 2026 · NCT05996328Assessment of CCM in HF With Higher Ejection Fraction
- Grandview Medical Group Research, LLC, Birmingham
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05064709A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10004 Fairhope, AL Investigational Site, Fairhope
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06033950Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function
- Auburn University, Auburn
Recruiting
Ages 55 and older · All sexes · Updated Mar 25, 2026 · NCT07489105AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- Eastern Shore Research Institute, Fairhope
RecruitingObservational study
Ages 22 and older · All sexes · Updated Mar 26, 2025 · NCT06378632Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
- Heart Center Research, LLC, Huntsville
RecruitingPhase 4
Ages 19 and older · All sexes · Updated Jan 29, 2024 · NCT06218199From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.